Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation

Robert Nee, Dennis Doppenschmidt, Daniel J. Donovan, Thomas C. Andrews

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

Our data suggest that compared with the subcutaneous route of administration, intravenous vitamin K1 results in a more prompt reduction in the international normalized ration. However, for most patients, subcutaneous vitamin K1 is an effective and safe alternative when used in conjunction with modification of subsequent warfarin dosing, because virtually all patients achieved a safe level of anticoagulation within 72 hours with this route of administration.

Original languageEnglish (US)
Pages (from-to)286-288
Number of pages3
JournalAmerican Journal of Cardiology
Volume83
Issue number2
DOIs
StatePublished - Jan 15 1999

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Intravenous versus subcutaneous vitamin K<sub>1</sub> in reversing excessive oral anticoagulation'. Together they form a unique fingerprint.

  • Cite this